Galderma joins the Swiss Market Index

Galderma Swiss Market Index dermatology SMI blue chip

Galderma has officially begun trading as a constituent of the Swiss Market Index (SMI), the benchmark index comprising 20 of Switzerland’s largest and most liquid listed companies. This inclusion comes less than three years after the company’s initial public offering on the SIX Swiss Exchange in March 2024.

The dermatology company reported significant financial growth, with net sales increasing from 4.410 billion USD in 2024 to 5.207 billion USD in 2025. In the first half of 2026, net sales grew by 24.6% year-on-year at constant currency. Due to this performance, Galderma raised its full-year 2026 net sales growth guidance to between 19% and 21% at constant currency.

Galderma’s shareholder base includes the L’Oréal Group, which holds 20% of the company’s shares, while the remaining 80% is in free float.

Entities

Galderma

Sources

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies [www.europesays.com]

2 days ago

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland’s Leading Blue Chip Companies [www.novumpr.nl]

2 days ago

Galderma Enters Switzerland’s Blue-Chip Index [businessnewsthisweek.com]

2 days ago